Table 1. Baseline demographics.
ARS, anticholinergic risk scale; BMI, body mass index; FCI, functional comorbidity index; LUTS, lower urinary tract symptom; POP, pelvic organ prolapse. Data are presented as mean ± standard deviation, median (25%, 75% quartile), or n (%).
| Variable | Placebo (n=10) |
Lidocaine (n=8) |
|---|---|---|
| Age (y) | 32 ± 10 | 30 ± 5 |
| Race | ||
| White | 7 (70) | 4 (50) |
| Black | 2 (20) | 1 (12.5) |
| Asian | 0 (0) | 1 (12.5) |
| Other | 1 (10) | 2 (25) |
| BMI (kg/m2) | 26 ± 6.9 | 24 ± 4.2 |
| Education | ||
| High school | 1 (10) | 0 (0) |
| College graduate | 3 (30) | 4 (50) |
| Graduate/professional | 6 (60) | 4 (50) |
| Mode of Delivery | ||
| Vaginal delivery | 5 (50) | 3 (37.5) |
| Cesarean section | 1 (10) | 1 (12.5) |
| Menopausal Status | ||
| Premenopausal | 9 (90) | 8 (100) |
| Postmenopausal | 1 (10) | 0 (0) |
| Smoker | 0 (0) | 0 (0) |
| Pelvic organ prolapse | 0 (0) | 0 (0) |
| ARS Score | 0 | 0 |
| FCI | 0.5 (0, 1.25) | 0 (0, 0) |
| LUTS Score | 5 ± 4 | 4 ± 3 |